explore -WSS

explore

author：knowledge 2025-08-04 12:34:06 - browse：35141

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Vertex cell therapy lets patients with type 1 diabetes stop insulin

WSS

Fatty liver disease was alleviated by Lilly’s ‘triple

Fatty liver disease was alleviated by Lilly’s ‘triple

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

VC firm RA Capital starts a new synthetic biology incubator

How Robert F. Kennedy Jr. distorted vaccine science

CDC: Cases of alpha

knowledge

explore

entertainment

Apple is now the first public company to be valued at $3 trillion

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Apple is now the first public company to be valued at $3 trillion

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Duchenne breakthrough therapy leaves behind pioneering families

Behind warning on Apellis’s eye drug lies a conflict of interest

DIEP, the 'gold standard' of breast reconstruction, is under threat

Canadians with cystic fibrosis outlive Americans by a decade

Heart attack and stroke risk calculators need revising

Use doctors trained outside the U.S. to ease the physician shortage

knowledge

CDC: Cases of alpha

Interest rates are at a 22

Behind warning on Apellis’s eye drug lies a conflict of interest

Marc Tessier

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

VC firm RA Capital starts a new synthetic biology incubator

leisure time

entertainment

leisure time

hotspot